Ironwood Pharmaceuticals, Inc.
IRWD
$0.5846
-$0.0098-1.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.39M | 2.26M | 3.65M | -860.00K | -4.16M |
| Total Depreciation and Amortization | 479.00K | 485.00K | 907.00K | 106.00K | 513.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.79M | 46.09M | 15.97M | 22.81M | 15.44M |
| Change in Net Operating Assets | 50.08M | -33.61M | -10.63M | 11.41M | 33.20M |
| Cash from Operations | 19.95M | 15.21M | 9.89M | 33.47M | 44.99M |
| Capital Expenditure | -31.00K | 0.00 | -16.00K | -58.00K | -68.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -31.00K | 0.00 | -16.00K | -58.00K | -68.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 150.00M | -- |
| Total Debt Repaid | -- | -15.00M | -25.00M | -200.00M | -25.00M |
| Issuance of Common Stock | 6.00K | 203.00K | 0.00 | 749.00K | 10.06M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -121.00K | -616.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -90.00K | -2.16M | -- | -- |
| Cash from Financing | 6.00K | -14.89M | -27.16M | -49.37M | -15.56M |
| Foreign Exchange rate Adjustments | -7.00K | 21.00K | -26.00K | -51.00K | 24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.92M | 348.00K | -17.31M | -16.02M | 29.39M |